logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Linjiang Tong

Chinese Academy of Sciences
H指数:33
被引数:3,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c] pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer

1,2,3,4-四氢苯并呋喃[2,3-c]吡啶衍生物的设计、合成及药理学评价：作为p21活化激酶4抑制剂用于胰腺癌治疗

ACTA PHARMACEUTICA SINICA B
IF14.6
2025-01-010
OAAI
Li, Yang; Fang, Yan; Chen, Xiaoyu; Tong, Linjiang; Feng, Fang; Zhou, Qianqian; Chen, Shulun; Ding, Jian; Xie, Hua; Zhang, Ao
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas

发现新的BTK抑制剂S-016并确定治疗淋巴瘤 (包括BTK抑制剂耐药淋巴瘤) 的新策略

ACTA PHARMACOLOGICA SINICA
IF8.4
2024-06-040
PRE
Song, Pei-ran; Wan, Zhi-peng; Huang, Ge-ge; Song, Zi-lan; Zhang, Tao; Tong, Lin-jiang; Fang, Yan; Tang, Hao-tian; Xue, Yu; Zhan, Zheng-sheng; Feng, Fang; Li, Yan; Shi, Wen-hao; Huang, Yu-qing; Chen, Yi; Duan, Wen-hu; Ding, Jian; Zhang, Ao; Xie, Hua
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma
ACTA PHARMACEUTICA SINICA B
IF14.6
2023-12-013
OAAI
Liu, Yingqiang; Zhan, Zhengsheng; Kang, Zhuang; Li, Mengyuan; Lv, Yongcong; Li, Shenglan; Tong, Linjiang; Feng, Fang; Li, Yan; Zhang, Mengge; Xue, Yaping; Chen, Yi; Zhang, Tao; Song, Peiran; Su, Yi; Shen, Yanyan; Sun, Yiming; Yang, Xinying; Yang, Hanyu; Wang, Caixia; Geng, Meiyu; Li, Wenbin; Duan, Wenhu; Chen, Yi; Xie, Hua; Yao, Shanyan; Ding, Jian

研究方向

暂未获取到该数据
丁
丁健
H 指数:63论文数:579被引数:1.6万
H
Hua Xie
H 指数:37论文数:311被引数:5,185
张
张涛
H 指数:27论文数:116被引数:4,151
Y
Yi Chen
H 指数:38论文数:189被引数:4,706
李
李洪林
H 指数:57论文数:730被引数:2.0万
丁
丁克
H 指数:65论文数:453被引数:1.4万
耿
耿美玉
H 指数:56论文数:546被引数:1.2万
段
段文虎
H 指数:36论文数:147被引数:4,004
陆
陆小云
H 指数:39论文数:198被引数:5,188
Y
Yufang Xu
H 指数:56论文数:303被引数:1.0万